Also Known As
CJC-1295 DAC · CJC-1295 no DAC · Mod GRF 1-29
Overview
CJC-1295 is a synthetic GHRH analog. The DAC (Drug Affinity Complex) version has extended half-life. Often paired with a GHRP for synergistic GH release.
Mechanism of Action
Stimulates the pituitary to release growth hormone by mimicking GHRH.
Quick Reference
Common Dose 100-300mcg
Frequency 1-3x daily (no DAC), 2x weekly (with DAC)
Half-Life 30 min (no DAC), 6-8 days (with DAC)
Storage Refrigerate reconstituted.
Dosing Protocol
Typical Dose 100 mcg
Range 100 - 300 mcg
Maintenance 100 mcg 2-3x daily
Pharmacokinetics
Half-Life 30 min
Onset 5 min
Peak 15 min
Duration 2.0 hrs
Bioavailability 95%
Primary Route Subcutaneous
Administration
Routes Subcutaneous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted, Post-Workout
Reconstitution
Diluent Bacteriostatic Water
Volume 2 mL
Concentration 1000 mcg/mL
Stability 21 days refrigerated
Vial Sizes 2, 5 mg
Special Instructions
Best combined with a GHRP like Ipamorelin for synergistic effect. Take on empty stomach.
Warnings
May affect blood glucose
Not FDA approved
Contraindications
PregnancyBreastfeedingActive CancerPituitary Tumors
Drug Interactions
InsulinCorticosteroids
Possible Side Effects
Water RetentionTinglingFlushingHeadache
Legal & Regulatory
FDA Status Research Only
WADA Status Prohibited in Sport
Prescription Not Required
Pregnancy
Category X - Contraindicated
Molecular Data
Formula C152H252N44O42
Molecular Weight 3367.9 g/mol
Amino Acids 29
CAS Number 863288-34-0
PubChem CID 91976842
No sources available yet.
Related Peptides
No community data available yet. Be the first to add this peptide to your inventory!